心力衰竭影响内皮细胞对心肺绕道心脏手术的反应
Olga Papazisi1, Rudmer J Postma2, Richard J Dirven3
1Department of Cardiothoracic Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Cells
|September 13, 2025
概括
患有心力衰竭和减少喷射分数 (HFrEF) 的患者表现出心肺绕道手术 (CPB) 的内皮细胞 (EC) 反应发生变化. 在HFrEF患者中,先前存在的EC功能障碍和线粒体问题可能会使他们倾向于术后血液动力学不稳定.
科学领域:
- 心血管生物学 心血管生物学
- 内皮细胞生物学 内皮细胞生物学
- 手术生理学 手术生理学
背景情况:
- 患有心力衰竭和减少射出分数 (HFrEF) 的患者在心肺绕道 (CPB) 心脏手术后经历血液动力学不稳定性和血管的风险增加.
- 慢性心力衰竭 (HF) 可能导致先前存在的内皮细胞 (EC) 改变,影响它们对心脏手术的反应,并导致术后血管功能障碍.
- 了解这些EC变化对于管理HFrEF患者的术后风险至关重要.
研究的目的:
- 研究HFrEF患者的内皮细胞 (EC) 激活标志物和反应,与接受心肺旁路 (CPB) 心脏手术的对照人群相比.
- 确定HFrEF患者先前存在的内皮细胞 (EC) 功能障碍是否有助于术后血动力学不稳定.
- 评估CPB对HFrEF患者EC功能和线粒体健康的影响.
主要方法:
- 从HFrEF和对照患者中采集了血液样本,用于通过ELISA测量angiopoietin 2 (ANG2),·威尔布兰德因子 (vWF) 和可溶性P-selectin.
- 培养的内皮细胞 (EC) 被暴露在患者衍生的血中,以分析形态变化和线粒体功能.
- 用线粒体测定和形态分析来评估EC反应.
主要成果:
- 与对照组相比,HFrEF患者的ANG2和vWF基线水平较高,两种标志物在术后达到峰值.
- 对患者血的内皮细胞 (EC) 反应显示出HFrEF和对照组之间明显的基线形态差异.
- 线粒体分析显示,在两组患者中, postoperative 功能和形态的改变,在 EC 对 HFrEF 血的反应中显著差异.
结论:
- HFrEF患者表现出对心肺旁路 (CPB) 心脏手术的内皮细胞 (EC) 反应.
- 在HFrEF血内稳定的循环因子有助于诱导EC压力.
- 在HFrEF患者中,先前存在的内皮细胞 (EC) 和线粒体功能障碍可能使其易患术后血动力学不稳定.
相关概念视频
01:29Heart Failure II: Pathophysiology
752
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
752
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:26Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
01:27Heart Failure I: Introduction
711
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
711
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
943
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
943
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
290
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
290